Suppressed rate of carcinogenesis and decreases in tumour volume and lung metastasis in CXCL14/BRAK transgenic miceRyu‐Ichiro Hata, Masaru Taniguchi|Scientific Reports|2015Cited by 44
Restoration of BRAK / CXCL14 gene expression by gefitinib is associated with antitumor efficacy of the drug in head and neck squamous cell carcinomaShigeyuki Ozawa, Ryu‐Ichiro Hata|Cancer Science|2009Cited by 44